Jehonathan Pinthus Selected Research

Gonadotropin-Releasing Hormone (GnRH)

1/2022	The cardiovascular effects of gonadotropin-releasing hormone antagonists in men with prostate cancer.
2/2020	Antagonizing GnRH receptors: A temporary ADT salvage maneuver for prostate cancer patients experiencing PSA failure with GnRH agonist.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jehonathan Pinthus Research Topics

Disease

8	Prostatic Neoplasms (Prostate Cancer) 03/2022 - 06/2005
4	Neoplasms (Cancer) 03/2022 - 06/2005
2	Cardiovascular Diseases (Cardiovascular Disease) 03/2022 - 11/2021
2	Renal Cell Carcinoma (Grawitz Tumor) 02/2009 - 06/2006
1	Sepsis (Septicemia) 03/2014
1	Myocardial Ischemia (Ischemic Heart Diseases) 03/2014
1	Melanoma (Melanoma, Malignant) 06/2005
1	Neoplasm Metastasis (Metastasis) 06/2005

Drug/Important Bio-Agent (IBA)

4	AndrogensIBA 03/2022 - 01/2020
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2022 - 02/2020
2	ErbB Receptors (EGF Receptor)IBA 01/2017 - 01/2017
1	Testosterone (Sustanon)FDA Link 01/2022
1	LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA 02/2020
1	Androgen Receptors (Androgen Receptor)IBA 01/2017
1	TroponinIBA 03/2014
1	Troponin T (Troponin T1)IBA 03/2014
1	KisspeptinsIBA 02/2009
1	Biomarkers (Surrogate Marker)IBA 01/2009
1	DNA (Deoxyribonucleic Acid)IBA 01/2009
1	OligonucleotidesIBA 06/2006
1	Neoplasm Antigens (Tumor Antigens)IBA 06/2005
1	Neoplasm AntibodiesIBA 06/2005
1	AntibodiesIBA 06/2005

Therapy/Procedure

5	Therapeutics 03/2022 - 06/2005
1	Castration 01/2016
1	Drug Therapy (Chemotherapy) 06/2005
1	Immunotherapy 06/2005